| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/07/2002 | CA2417340A1 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP0832267B1 Adenovirus vectors for gene therapy |
| 02/05/2002 | US6344354 Influenza virus replicated in mammalian cell culture and vaccine production |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344195 Administering reovirus to a ras-mediated neoplasm |
| 02/05/2002 | US6344193 Insect control method with genetically engineered biopesticides |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | WO2002008390A2 Bovine wasting syndrome vaccine |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008264A2 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002007742A2 Bacteriophage having multiple host range |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001052887A3 Vaccination against canine herpesvirus infection and vaccines |
| 01/31/2002 | WO2000057910A9 Attenuated dengue-4 virus vaccine |
| 01/31/2002 | US20020012997 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment |
| 01/31/2002 | US20020012671 Channel forming toxins as antiviral agents |
| 01/31/2002 | US20020012670 Vaccines, therapy, prophylaxis |
| 01/31/2002 | US20020012668 Used in diagnostics, detection of the bacteria Salmonella.typhi or in the production of vaccines for typhoid fever |
| 01/31/2002 | CA2418333A1 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | CA2417188A1 Bacteriophage having multiple host range |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175486A2 Method for the preservation of viruses and mycoplasma |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333693A ordered molecualr presentation of antigens, method of preparation and use |
| 01/30/2002 | CN1333689A Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 01/30/2002 | CN1333378A Diagnose test |
| 01/30/2002 | CN1333338A Papilloma pseudovirus and process for preparing same |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342390 Integration of dna into chromosome of cell; does not generate virus particles; genetic expression and engineering |
| 01/29/2002 | US6342384 Inoculation in capillary system; infecting with lytic virus; culturing cells; harvesting; storage stability |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342228 Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006303A2 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001038498A3 A new genotype of hepatitis b virus |
| 01/24/2002 | WO2000073478A9 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009707 Method for the inactivation of viruses |
| 01/24/2002 | US20020009462 Herpesvirus replication defective mutants |
| 01/24/2002 | DE10122233A1 Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen Using strains of Parapoxvirus ovis against organ fibrosis |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
| 01/23/2002 | EP1173598A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173596A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 01/23/2002 | EP1173595A1 Use of coxsackie viruses for improving cell transfection |
| 01/23/2002 | EP1173585A1 Epoxide hydrolases of aspergillus origin |
| 01/23/2002 | EP1173551A2 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/23/2002 | CN1332796A Method for separating viral particles |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/23/2002 | CN1332251A Production process of infections chicken cloacal bursa virus resisting monoclonal antibody |
| 01/23/2002 | CN1332239A Hepatitis B virus complete-genome polymerase chimera and its construction process and application |
| 01/23/2002 | CN1331914A Breeding method of black leg-resisting tobacco variety 'Honghuadajinyuan' |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/17/2002 | WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | WO2002004596A2 Diagnosing and treating cancer cells using mutant viruses |
| 01/17/2002 | WO2002004595A2 Production of chimeric human papillomavirus |
| 01/17/2002 | WO2002004494A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 01/17/2002 | WO2002004019A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 01/17/2002 | WO2002004007A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 01/17/2002 | WO2002003917A2 Alphavirus vectors and virosomes with modified hiv genes for use as vaccines |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001040455A3 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 01/17/2002 | US20020006398 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 01/17/2002 | US20020006395 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 01/17/2002 | CA2416203A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | CA2415763A1 Production of chimeric human papillomavirus |
| 01/16/2002 | EP1171624A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 01/16/2002 | EP1171623A2 Production of attenuated negative stranded rna virus vaccines |
| 01/16/2002 | EP1171608A2 Recombinant and mutant marek's disease virus |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0603386B1 Parenteral immunization against rotavirus |
| 01/16/2002 | EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338846 Genomes with transcription units |
| 01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | WO2002002752A1 Attenuated bovine respiratory syncytial virus |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002605A2 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001055362A3 Hybrid adeno-retroviral vector for the transfection of cells |
| 01/10/2002 | WO2001051066A3 Reduction in bacterial colonization by administering bacteriophage compositions |
| 01/10/2002 | WO2001051027A3 Polymer blends as biodegradable matrices for preparing biocomposites |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001037656A3 Preservation of sensitive biological material |
| 01/10/2002 | WO2001036615A3 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |